The diurnal variability of blood pressure in patients with hypertension and rheumatoid arthritis;Diurnální variabilita krevnflio tlaku u pacientů s hypertenzí a revmatoidní artritidou

Vnitrni Lekarstvi

Volumn 55, Issue 2, 2009, Pages 111-116

  Rihacek I ^a   Frana P ^a   Soucek M ^a   Plachy M ^a   Kianicka B ^a  

^a ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

Author keywords

24h ambulatory blood pressure monitoring; Cardiovascular risk; Diurnal variability of blood pressure; Hypertension; Rheumatoid arthritis

Indexed keywords

METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CIRCADIAN RHYTHM; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PREVALENCE; PULSE PRESSURE; RHEUMATOID ARTHRITIS; SYSTOLIC BLOOD PRESSURE;

ARTHRITIS, RHEUMATOID; BLOOD PRESSURE; CIRCADIAN RHYTHM; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED;

EID: 62349095240     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Kaplan MJ. Cardiovascular disease in rheumatoid arthritis. CurrOpion Rheumatol 2006; 18: 289-297.
2. WidimskýJ, Qfková R, ŠpinarJ et al. Doporučei'́ diagnostických a léčebnych postupů u arteriálni'́ hypertenze - verze 2007. Doporučení Ceske společnosti pro hypertenzi. Vnitř Lék 2008; 54: 101-118.
3. Panoulas VF, Douglas KM, Milionis HJ et al. Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis. Rheumatology (Oxford) 2007; 46: 1477-1482.
4. Trnavský K. Léčebna péče v revmacologii. Praha: Crada-Avicenum 1993.
5. 41st World Medical Assembly. Declaration of Helsinki: recommendations guiding physicians in biomedical research involving human subjects. Bull Pan Am Health Organ 1990; 24: 606-609.
6. Nemec P, Pavkova-Coldbergova M, Gat- terovaj et al. Association of the 5A/6A promoter polymorphism of the MMP-3 gene with the radiographic progression of rheumatoid arthritis. Ann NY Acad Sci 2007; 1110: 166-176.
7. Nemec P, Pavkova-Goldbergova M, Stouracova M et al. Polymorphism in the tumor necrosis factor-alpha gene promoter is associated with seventy of rheumatoid arthritis in the Czech population. Clin Rheumatol 2008; 27: 59-65.
8. WidimskyJ a kol. Hypertenze. Praha: Triton 2008.
9. Hamada T, Murata T, Narita K et al. The clinical significance of abnormal diurnal blood pressure variation in healthy late middle-aged and older adults. Blood Press 2008; 17: 134-140.
10. Pierdomenico SD, Lapenna D, Bucci A et al. Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant and true resistant hypertension. Am J Hypertens 2005; 18: 1422-1428.
11. Peixoto AJ, White WB. Orcadian blood pressure: clinical implications based on the pathophysiology of its variability. Kidney Int2007; 71: 855-860.
12. Staessen JA, Bieniaszewski L, O'Brien E et al. Nocturnal blood pressure fall on ambulatory monitoring in a large international database. The "Ad Hoc" Working Group. Hypertension 1997; 29: 30-39.
13. Cuspidi C, Meani S, Salerno M et al. Reproducibility of nocturnal blood pressure fall in early phases of untreated essential hypertension: a prospective observational study. J Hum Hypertens 2004; 18: 503-509.
14. Morrison A, Ramey DR, van Adelsberg J et al. Systematic review of trials of the effect of continued use of oral non-selective NS- AIDs on blood pressure and hypertension. Curr Med Res Opin 2007; 23: 2395-2404.
15. BečvářR, VencovskýJ, Němec Petal. Do- poručení České revmatologické společnosti pro léčbu revmatoidni artritidy. Ucinnost a strategie léčby. Vnitř Lék 2008; 54: 84-99.